Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. More Details
Slightly overvalued with imperfect balance sheet.
Share Price & News
How has Yestar Healthcare Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2393 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 2393's weekly volatility (3%) has been stable over the past year.
7 Day Return
HK Medical Equipment
1 Year Return
HK Medical Equipment
Return vs Industry: 2393 underperformed the Hong Kong Medical Equipment industry which returned 71% over the past year.
Return vs Market: 2393 underperformed the Hong Kong Market which returned 28.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Yestar Healthcare Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StThese 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
1 month ago | Simply Wall StWhat Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?
2 months ago | Simply Wall StThe Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come
Is Yestar Healthcare Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 2393 (HK$1.15) is trading below our estimate of fair value (HK$11.59)
Significantly Below Fair Value: 2393 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 2393 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.
PE vs Market: 2393 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2393's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2393's PB Ratio (3x) is in line with the HK Medical Equipment industry average.
How is Yestar Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2393's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if 2393's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2393's revenue (11.1% per year) is forecast to grow slower than the Hong Kong market (12.8% per year).
High Growth Revenue: 2393's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2393's Return on Equity is forecast to be very high in 3 years time (42.5%).
How has Yestar Healthcare Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2393 is currently unprofitable.
Growing Profit Margin: 2393 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 2393 is unprofitable, and losses have increased over the past 5 years at a rate of 43.3% per year.
Accelerating Growth: Unable to compare 2393's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2393 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (19.7%).
Return on Equity
High ROE: 2393 has a negative Return on Equity (-75.41%), as it is currently unprofitable.
How is Yestar Healthcare Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 2393's short term assets (CN¥2.8B) do not cover its short term liabilities (CN¥3.3B).
Long Term Liabilities: 2393's short term assets (CN¥2.8B) exceed its long term liabilities (CN¥511.1M).
Debt to Equity History and Analysis
Debt Level: 2393's debt to equity ratio (192.4%) is considered high.
Reducing Debt: 2393's debt to equity ratio has increased from 46% to 192.4% over the past 5 years.
Debt Coverage: 2393's debt is well covered by operating cash flow (40.7%).
Interest Coverage: 2393 is unprofitable, therefore interest payments are not well covered by earnings.
What is Yestar Healthcare Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2393's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2393's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2393's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2393's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2393 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2393's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
James Hartono (44 yo)
Mr. James Hartono serves as the Chairman of The Board and Chief Executive Officer of Yestar Healthcare Holdings Company Limited (formerly known as Yestar International Holdings Company Limited). Mr. Harton...
CEO Compensation Analysis
Compensation vs Market: James's total compensation ($USD574.92K) is above average for companies of similar size in the Hong Kong market ($USD316.42K).
Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.
Experienced Management: 2393's management team is considered experienced (4.5 years average tenure).
Experienced Board: 2393's board of directors are considered experienced (7.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Yestar Healthcare Holdings Company Limited's company bio, employee growth, exchange listings and data sources
- Name: Yestar Healthcare Holdings Company Limited
- Ticker: 2393
- Exchange: SEHK
- Founded: 1971
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: HK$2.705b
- Shares outstanding: 2.35b
- Website: https://www.yestarcorp.com
Number of Employees
- Yestar Healthcare Holdings Company Limited
- Green Land Building
- Floor 8, Block A
- Shanghai Province
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/05 10:23|
|End of Day Share Price||2021/05/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.